Paper Details

  1. Home
  2. Paper Details

Comparative efficacy of 3-day and 7-day chemotherapy with twice-daily pivmecillinam in urinary tract infections seen in general practice.

Author: RichardsH H

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Pivmecillinam, a drug used to treat acute urinary tract infections, was equally effective when administered for 3 or 7 days. Side effects were reported in a small number of patients.
Paper Details　
Original Abstract of the Article :
In a multi-centre general practice study, 183 females suffering from symptoms of acute urinary tract infection were randomly assigned to receive 400 mg pivmecillinam twice-daily for either 3 or 7 days. The clinical response was equally good in both treatment groups with a mean reduction in symptom s...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1185/03007998409109580

データ提供：米国国立医学図書館（NLM）

Pivmecillinam: A Powerful Antibiotic for Urinary Tract Infections

Urinary tract infections (UTIs) are a common ailment, often requiring antibiotic treatment. This research explores the efficacy of pivmecillinam, a commonly used antibiotic for UTIs, comparing the effectiveness of 3-day versus 7-day treatment regimens. The researchers investigated the clinical and bacteriological responses to pivmecillinam in a multi-center general practice study involving female patients with symptoms of acute UTI.

Pivmecillinam: A Short-Term Treatment Option for Urinary Tract Infections

The study results demonstrate that both 3-day and 7-day treatment regimens with pivmecillinam are equally effective in managing urinary tract infections. The clinical response was similar in both groups, with a significant reduction in symptom scores. Bacteriological cure was achieved in the majority of patients, indicating the strong antimicrobial efficacy of pivmecillinam. These findings suggest that a shorter 3-day course of pivmecillinam may be as effective as a longer 7-day regimen, potentially reducing the duration of treatment and minimizing potential side effects.

Managing Urinary Tract Infections Effectively

This study provides valuable insights into the management of urinary tract infections. The findings suggest that pivmecillinam is an effective antibiotic for UTIs, and a shorter 3-day treatment regimen may be sufficient for many patients. It's important to consult with a healthcare provider to receive a proper diagnosis and discuss the best treatment options for your specific situation. It's also important to stay hydrated, maintain good hygiene, and engage in regular urination to prevent UTIs.

Dr.Camel's Conclusion

Urinary tract infections are like desert mirages, appearing suddenly and causing discomfort. This research suggests that pivmecillinam is a powerful tool for dispelling these mirages. The study's findings on the effectiveness of short-term treatment provide valuable information for managing UTIs effectively and efficiently. Always consult with a healthcare professional for personalized advice and treatment plans.

Date :
  1. Date Completed 1984-12-26
  2. Date Revised 2019-09-08
Further Info :

Pubmed ID

6499513

DOI: Digital Object Identifier

10.1185/03007998409109580

Related Literature

Article Analysis
・Side Effects of pivmecillinam
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.